Feasibility of multimodality treatment, including pleurectomy decortication, in carefully selected patients with sarcomatoid mesothelioma

Puntos clave

• Median survival for patients with sarcomatoid mesothelioma undergoing surgery is under one year, highlighting poor outcomes.
• A small subset of patients with FEV1 ≥80% show promising results using a multimodality treatment approach.
• This analysis focuses on patients specifically selected for pleurectomy decortication as part of their treatment.
• These findings may indicate a need for targeted therapy in select cases, yet further studies are warranted.